WWOX expression in colorectal cancer-a real-time quantitative RT-PCR study

Tumor Biology

Volumn 32, Issue 3, 2011, Pages 551-560

  Zelazowski, MacIej Jakub ^a   Płuciennik, Elzbieta ^a   Pasz Walczak, Grazyna ^a   Potemski, Piotr ^a   Kordek, Radzisław ^a   Bednarek, Andrzej Kazimierz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

BCL2; Colorectal cancer; CpG methylation; LOH; Quantitative RT PCR; WWOX

Indexed keywords

ADULT; AGED; ARTICLE; BAX GENE; CANCER LOCALIZATION; CANCER SURVIVAL; CELL CYCLE REGULATION; COLORECTAL CANCER; CONTROLLED STUDY; CYCLIN D1 GENE; CYCLIN E1 GENE; DISEASE FREE SURVIVAL; DNA METHYLATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WW DOMAIN CONTAINING OXIDOREDUCTASE GENE; COLORECTAL TUMOR; GENETICS; METHODOLOGY; MIDDLE AGED; MORTALITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CADHERIN; CDH1 PROTEIN, HUMAN; MESSENGER RNA; OXIDOREDUCTASE; TUMOR SUPPRESSOR PROTEIN; WWOX PROTEIN, HUMAN;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; OXIDOREDUCTASES; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 79960652202     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0150-5     Document Type: Article

References (40)

1. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 2000;60(8):2140-5. (Pubitemid 30225175)
2. Paige AJ, Taylor KJ, Taylor C, Hillier SG, Farrington S, Scott D, et al. WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci USA. 2001;98(20):11417-22. (Pubitemid 32928743)
3. Salah Z, Aqeilan R, Huebner K. WWOX gene and gene product: tumor suppression through specific protein interactions. Future Oncol. 2010;6(2):249-59.
4. Aqeilan RI, Donati V, Palamarchuk A, Trapasso F, Kaou M, Pekarsky Y, et al. WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res. 2005;65(15):6764-72. (Pubitemid 41060714)
5. Aqeilan RI, Hassan MQ, de Bruin A, Hagan JP, Volinia S, Palumbo T, et al. The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem. 2008;283(31):21629-39.
6. Bouteille N, Driouch K, Hage PE, Sin S, Formstecher E, Camonis J, et al. Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein. Oncogene. 2009;28(28):2569-80.
7. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, et al. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res. 2001;61 (22):8068-73. (Pubitemid 33091591)
8. Aqeilan RI, Croce CM. WWOX in biological control and tumorigenesis. J Cell Physiol. 2007;212(2):307-10. (Pubitemid 47025619)
9. Alsop AE, Taylor K, Zhang J, Gabra H, Paige AJ, Edwards PA. Homozygous deletions may be markers of nearby heterozygous mutations: the complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX. Genes Chromosom Cancer. 2008;47(5):437-47. (Pubitemid 351451798)
10. Kuroki T, Yendamuri S, Trapasso F, Matsuyama A, Aqeilan RI, Alder H, et al. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res. 2004;10 (7):2459-65. (Pubitemid 38445707)
11. Iliopoulos D, Guler G, Han SY, Johnston D, Druck T, McCorkell KA, et al. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene. 2005;24(9):1625-33. (Pubitemid 40396092)
12. Pluciennik E, Kusinska R, Potemski P, Kubiak R, Kordek R, Bednarek AK. WWOX-the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. Eur J Surg Oncol. 2006;32(2):153-7. (Pubitemid 43257115)
13. Aqeilan RI, Donati V, Gaudio E, Nicoloso MS, Sundvall M, Korhonen A, et al. Association of Wwox with ErbB4 in breast cancer. Cancer Res. 2007;67(19):9330-6. (Pubitemid 47535922)
14. Iliopoulos D, Fabbri M, Druck T, Qin HR, Han SY, Huebner K. Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression. Clin Cancer Res. 2007;13 (1):268-74. (Pubitemid 46121879)
15. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7): RESEARCH0034.
16. Chen T, Sahin A, Aldaz CM. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res. 1996;56(24):5605-9. (Pubitemid 26422160)
17. Holemon H, Korshunova Y, Ordway JM, Bedell JA, Citek RW, Lakey N, et al. MethylScreen: DNA methylation density monitoring using quantitative PCR. Biotechniques. 2007;43(5):683-93. (Pubitemid 350174919)
18. Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252-9. (Pubitemid 39487712)
19. Ding Y, Xu L, Jovanovic BD, Helenowski IB, Kelly DL, Catalona WJ, et al. The methodology used to measure differential gene expression affects the outcome. J Biomol Tech. 2007;18(5):321-30.
20. Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M, et al. WWOX expression in different histologic types and subtypes of non-small cell lung cancer. Clin Cancer Res. 2007;13(3):884-91. (Pubitemid 46340363)
21. Nunez MI, Rosen DG, Ludes-Meyers JH, Abba MC, Kil H, Page R, et al. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer. 2005;5(1):64.
22. Cantor JP, Iliopoulos D, Rao AS, Druck T, Semba S, Han SY, et al. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer. 2007;120(1):24-31. (Pubitemid 44901913)
23. Qin HR, Iliopoulos D, Semba S, Fabbri M, Druck T, Volinia S, et al. A role for the WWOX gene in prostate cancer. Cancer Res. 2006;66(13):6477-81. (Pubitemid 44085599)
24. Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, Pekarsky Y, et al. Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci USA. 2007;104 (10):3949-54. (Pubitemid 47181559)
25. Driouch K, Dorion-Bonnet F, Briffod M, Champeme MH, Longy M, Lidereau R. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosom Cancer. 1997;19 (3):185-91. (Pubitemid 27278806)
26. Yakicier MC, Legoix P, Vaury C, Gressin L, Tubacher E, Capron F, et al. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Onco-gene. 2001;20(37):5232-8. (Pubitemid 32844054)
27. Yendamuri S, Kuroki T, Trapasso F, Henry AC, Dumon KR, Huebner K, et al. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res. 2003;63(4):878-81. (Pubitemid 36231991)
28. Kuroki T, Trapasso F, Shiraishi T, Alder H, Mimori K, Mori M, et al. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res. 2002;62 (8):2258-60. (Pubitemid 34411701)
29. Aqeilan RI, Kuroki T, Pekarsky Y, Albagha O, Trapasso F, Baffa R, et al. Loss of WWOX expression in gastric carcinoma. Clin Cancer Res. 2004;10(9):3053-8. (Pubitemid 38619682)
30. Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Muller SC, von Rucker A. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy. Eur Urol. 2007;51(3):665-74. (Pubitemid 46097267)
31. Kosla K, Pluciennik E, Kurzyk A, Jesionek-Kupnicka D, Kordek R, Potemski P, et al. Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme. J Neurooncol. 2011;101(2):207-13.
32. Hunt KK, Keyomarsi K. Cyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol. 2005;15(4):319-26. (Pubitemid 41058777)
33. Abaza MS, Al Saffar A, Al Sawan S, Al Attiyah R. c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs. Tumour Biol. 2008;29(5):287-303.
34. Anjomshoaa A, Lin YH, Black MA, McCall JL, Humar B, Song S, et al. Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer. Br J Cancer. 2008;99(6):966-73.
35. Li D, Das S, Yamada T, Samuels HH. The NRIF3 family of transcriptional coregulators induces rapid and profound apoptosis in breast cancer cells. Mol Cell Biol. 2004;24(9):3838-48. (Pubitemid 38496162)
36. Efstathiou JA, Liu D, Wheeler JM, Kim HC, Beck NE, Ilyas M, et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci USA. 1999;96(5):2316-21. (Pubitemid 29117912)
37. Jenab M, McKay JD, Ferrari P, Biessy C, Laing S, Munar GM, et al. CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer. 2008;44(6):774-80.
38. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65(23):3756-88.
39. Liu Y, Zhao Y, Wu C, Ho KS, Koh PK, Chong SF, et al. Modest promoter methylation of E-cadherin gene in sporadic colorectal cancers: a quantitative analysis. Cancer Biomark. 2008;4(2):111-20. (Pubitemid 351712271)
40. Guler G, Huebner K, Himmetoglu C, Jimenez RE, Costinean S, Volinia S, et al. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer. Cancer. 2009;115(4):899-908.